Warren Hosseinion - 25 Feb 2021 Form 4 Insider Report for Clinigence Holdings, Inc. (NUTX)

Role
Chief Executive Officer, Director
Signature
Warren Hosseionion
Issuer symbol
NUTX
Transactions as of
25 Feb 2021
Net transactions value
+$1,968,192
Form type
4
Filing time
21 Dec 2021, 12:10:04 UTC
Next filing
08 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Other $1,824,186 +894,209 +347% $2.04* 1,151,563 25 Feb 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Director Stock Option (right to buy) Purchase +800,000 800,000 27 Jan 2020 Common Stock 800,000 Direct F2
transaction NUTX Warrants to Puchase common stock Purchase $144,005 +21,590 $6.67* 21,590 19 Mar 2019 Common Stock 21,590 $6.67 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as per merger exchange.
F2 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030